3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow whole grape extract: new trials by email Literature Review of whole grape extract trials Research Report on whole grape extract
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Impact of Grape Consumption on Brain Metabolism and Neuropsychological Performance Over 1 Year Grape Powder, Placebo Powder - Mild Cognitive Impairment | Phase 2 | Completed | University of California, Los Angeles | 32 | 2017-11-18 | 2023-02-21 |
| Effect of Pterostilbene on Cholesterol, Blood Pressure and Oxidative Stress Pterostilbene 50 mg twice daily, Placebo, Grape Extract - Hyperlipidemia, Blood Pressure | Phase 2 / Phase 3 | Completed | University of Mississippi Medical Center | 80 | 2010-12-01 | 2018-01-10 |
| Resveratrol-enriched Grape Extract (Stilvid) in Primary and Secondary Prevention of Cardiovascular Disease Placebo in primary cardiovascular prevention (PP), Placebo in secondary prevention, Grape extract in primary prevention (PP) - Cardiovascular Diseases | Phase 2 | Completed | National Research Council, Spain | 150 | 2009-04-01 | 2011-11-16 |
Alzheimer Disease (1) · Brain Diseases (1) · Cardiovascular Diseases (1) · Central Nervous System Diseases (1) · Cognitive Dysfunction (1) · Dementia (1) · Hyperlipidemias (1)
National Research Council, Spain (1) · University of California, Los Angeles (1) · University of Mississippi Medical Center (1)
United States (2) · Spain (1)
Daniel H Silverman, MD, PhD (1) · Daniel M Riche, Pharm.D. (1)